3 studies found for:    19628174 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Immunologic Response After Pandemic Influenza A (H1N1) Vaccine in Onco- Hematologic Patients
Conditions: Lymphoma;   Multiple Myeloma;   Myeloproliferative Disease
Intervention: Biological: Reassortant vaccine virus NYMC X-179A (New York Medical College, New York) derived form the A/california/7/2009 (H1N1) virus
2 Completed Immunogenicity, Safety, and Tolerability of MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With HIV-1 Infection
Conditions: H1N1 Influenza Virus;   Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Interventions: Biological: Focetria®;   Biological: Begrivac®
3 Completed Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors
Conditions: H1N1 Influenza Virus;   Invasive Solid Tumors
Interventions: Biological: adjuvanted A(H1N1) influenza vaccine;   Biological: non-adjuvanted A(H1N1) influenza vaccine

Indicates status has not been verified in more than two years